Haleos Labs Limi

{
  "main_header": {
    "sid": 1002809,
    "name": "Haleos Labs Limi",
    "stock_name": "Haleos Labs Limi",
    "full_name": "Haleos Labs Limited",
    "name_url": "stocks-analysis/haleos-labs-limi",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,253.80",
    "chg": 54.4,
    "chgp": "4.54%",
    "dir": 1,
    "prev_price": "1,199.40",
    "mcapval": "363.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540679,
    "symbol": "HALEOSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE320X01016",
    "curr_date": "Apr 01",
    "curr_time": "",
    "bse_nse_vol": "499 ",
    "exc_status": "Active",
    "traded_date": "Apr 01, 2026",
    "traded_date_str": "2026 04 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haleos-labs-limi-1002809-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-upper-circuit-amid-strong-buying-pressure-3928914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_stocks_hitting_upper_circuit_3928914.png",
        "date": "2026-04-01 11:00:23",
        "description": "At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-3917690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3917690.png",
        "date": "2026-03-26 08:13:14",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-3893359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3893359.png",
        "date": "2026-03-16 10:10:02",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 4 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3872894",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3872894.png",
        "date": "2026-03-05 08:31:10",
        "description": "Haleos Labs Limited, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, signalling a cautious but more optimistic outlook for investors amid mixed fundamental signals."
      },
      {
        "title": "Haleos Labs Limited is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-3857770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_mojoScore_3857770.png",
        "date": "2026-02-26 10:10:50",
        "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-by-marketsmojo-3839063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_mojoScore_3839063.png",
        "date": "2026-02-14 10:10:31",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Are Haleos Labs Limited latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-haleos-labs-limited-latest-results-good-or-bad-3835929",
        "imagepath": "",
        "date": "2026-02-12 20:02:58",
        "description": "Haleos Labs Limited's latest financial results for Q3 FY26 reveal a complex operational landscape characterized by robust revenue growth alongside margin pressures. The company achieved net sales of ₹94.78 crores, marking a year-on-year increase of 12.03% from ₹84.60 crores in Q3 FY25. This performance represents the highest quarterly revenue in the company's history and signifies a sequential growth of 16.48% from the previous quarter, indicating strong market demand and potential successful product launches.\n\nHowever, the profitability metrics present a more nuanced picture. The net profit for the quarter reached ₹6.62 crores, reflecting a year-on-year growth of 21.02% compared to ₹5.47 crores in Q3 FY25. Despite this positive trajectory in profit, the operating margin contracted to 14.82%, down from 16.69% in the prior quarter, indicating rising cost pressures that are absorbing some of the revenue gains..."
      },
      {
        "title": "Haleos Labs Q3 FY26: Strong Quarter Drives Margin Recovery Despite Sector Headwinds",
        "link": "https://www.marketsmojo.com/news/result-analysis/haleos-labs-q3-fy26-strong-quarter-drives-margin-recovery-despite-sector-headwinds-3835266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_quaterlyResult_3835266.png",
        "date": "2026-02-12 09:53:56",
        "description": "Haleos Labs Limited (NSE: HALEOSLABS), a micro-cap pharmaceutical company with a market capitalisation of ₹379.42 crores, delivered its strongest quarterly performance in Q3 FY26 (October-December 2025), posting consolidated net profit of ₹6.62 crores—an 8.52% quarter-on-quarter increase and a robust 21.02% year-on-year growth. The Hyderabad-based company, which operates in the highly competitive pharmaceuticals and biotechnology sector, saw its stock trading at ₹1,255.00 as of February 12, 2026, down 1.27% on the day but reflecting a complex narrative of operational improvement amidst valuation concerns."
      },
      {
        "title": "When is the next results date for Haleos Labs Limited?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-haleos-labs-limited-3823252",
        "imagepath": "",
        "date": "2026-02-05 23:18:32",
        "description": "Haleos Labs Limited is scheduled to declare its results on 11 February 2026...."
      }
    ],
    "total": 435,
    "sid": "1002809",
    "stock_news_url": "https://www.marketsmojo.com/news/haleos-labs-limited-1002809"
  },
  "announcements": [
    {
      "caption": "New Email ID & Website",
      "datetime": "30-Mar-2026",
      "details": "Communication to Shareholders",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "30-Mar-2026",
      "details": "Postal Ballot Notice (31.03.2026 to 29.04.2026)",
      "source": "BSE"
    },
    {
      "caption": "Events Calendar (Postal Ballot)",
      "datetime": "26-Mar-2026",
      "details": "Enclosed - events calendar for Postal Ballot.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Haleos Labs Limited has declared <strong>15%</strong> dividend, ex-date: 24 Sep 25",
          "dt": "2025-09-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-04-01 11:00:23

At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness

2026-03-26 08:13:14

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters.

Read full news article

Haleos Labs Limited is Rated Hold

2026-03-16 10:10:02

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 4 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-03-05 08:31:10

Haleos Labs Limited, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, signalling a cautious but more optimistic outlook for investors amid mixed fundamental signals.

Read full news article

Haleos Labs Limited is Rated Sell

2026-02-26 10:10:50

Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Haleos Labs Limited is Rated Hold by MarketsMOJO

2026-02-14 10:10:31

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Are Haleos Labs Limited latest results good or bad?

2026-02-12 20:02:58

Haleos Labs Limited's latest financial results for Q3 FY26 reveal a complex operational landscape characterized by robust revenue growth alongside margin pressures. The company achieved net sales of ₹94.78 crores, marking a year-on-year increase of 12.03% from ₹84.60 crores in Q3 FY25. This performance represents the highest quarterly revenue in the company's history and signifies a sequential growth of 16.48% from the previous quarter, indicating strong market demand and potential successful product launches. However, the profitability metrics present a more nuanced picture. The net profit for the quarter reached ₹6.62 crores, reflecting a year-on-year growth of 21.02% compared to ₹5.47 crores in Q3 FY25. Despite this positive trajectory in profit, the operating margin contracted to 14.82%, down from 16.69% in the prior quarter, indicating rising cost pressures that are absorbing some of the revenue gains...

Read full news article

Haleos Labs Q3 FY26: Strong Quarter Drives Margin Recovery Despite Sector Headwinds

2026-02-12 09:53:56

Haleos Labs Limited (NSE: HALEOSLABS), a micro-cap pharmaceutical company with a market capitalisation of ₹379.42 crores, delivered its strongest quarterly performance in Q3 FY26 (October-December 2025), posting consolidated net profit of ₹6.62 crores—an 8.52% quarter-on-quarter increase and a robust 21.02% year-on-year growth. The Hyderabad-based company, which operates in the highly competitive pharmaceuticals and biotechnology sector, saw its stock trading at ₹1,255.00 as of February 12, 2026, down 1.27% on the day but reflecting a complex narrative of operational improvement amidst valuation concerns.

Read full news article

When is the next results date for Haleos Labs Limited?

2026-02-05 23:18:32

Haleos Labs Limited is scheduled to declare its results on 11 February 2026....

Read full news article

View All News